-
- Australia
- Canada
- UK
- USA
- Afghanistan
- Albania
- Algeria
- American Samoa
- Andorra
- Angola
- Anguilla
- Antarctica
- Antigua and Barbuda
- Argentina
- Armenia
- Aruba
- Australia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bermuda
- Bhutan
- Bolivia
- Bosnia and Herzegovina
- Botswana
- Brazil
- British Indian Ocean Territory
- Brunei Darussalam
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Cape Verde
- Cayman
- Central African R
- Chad
- Chile
- China
- Cocos (Keeling)
- Colombia
- Comoros
- Congo, The DR
- Congo, Rep of
- Cook Is
- Costa Rica
- Cote d'Ivoire
- Croatia/Hrvatska
- Cuba
- Cyprus
- Czech Repu
- Denmark
- Djibouti
- Dominica
- Dominican R
- Timor-Leste
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Ethiopia
- Falklands (Malvinas)
- Fiji
- Finland
- France
- French Guiana
- French Polynesia
- French Southern Territories
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Gibraltar
- Greece
- Greenland
- Grenada
- Guadeloupe
- Guam
- Guatemala
- Guernsey
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Heard and McDonald Is
- Holy See (Vatican City State)
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Isle of Man
- Israel
- Italy
- Jamaica
- Japan
- Jersey
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Korea, DPR
- Korea, Repub of
- Kuwait
- Kyrgyzstan
- Lao
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libyan Arab Jamahiriya
- Liechtenstein
- Lithuania
- Luxembourg
- Montenegro
- Macau
- Macedonia
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Is
- Martinique
- Mauritania
- Mauritius
- Mayotte
- Mexico
- Micronesia, Federal State of
- Moldova
- Monaco
- Mongolia
- Montserrat
- Morocco
- Mozambique
- Myanmar
- Namibia
- Nauru
- Nepal
- Netherlands
- Netherlands Antilles
- New Caledonia
- New Zealand
- Nicaragua
- Niger
- Nigeria
- Niue
- Norway
- Oman
- Pakistan
- Palau
- Palestinian Territories
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Pitcairn
- Poland
- Portugal
- Puerto Rico
- Qatar
- Reunion
- Romania
- Russian Federation
- Rwanda
- Serbia
- St Kitts and Nevis
- Snt Lucia
- Sa Vincent and the Grenadines
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Seychelles
- Sierra Leone
- Singapore
- Slovak R
- Slovenia
- Solomons
- Somalia
- South Africa
- South Georgia and the South Sandwich
- Spain
- Sri Lanka
- S Helena
- S Pierre and Miquelon
- Sudan
- Suriname
- Svalbard and Jan Mayen
- Swaziland
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Togo
- Tokelau
- Tonga
- Trinidad and Tobago
- Tunisia
- Turkey
- Turkmenistan
- Turks and Caicos
- Tuvalu
- Uganda
- Ukraine
- Unitd Arab Emirates
- UK
- USA
- Uruguay
- Uzbekistan
- Vanuatu
- Venezuela
- Vietnam
- Virgin Is, British
- Virgin Is, U.S.
- Wallis and Futuna
- Western Sahara
- Western Samoa
- Yemen
- Yugoslavia
- Zambia
- Zimbabwe
- Gift certificates
- Academic eBooks
- My account
- Help
- Wishlist
- Feedback
- Sign up
The Leading eBooks Store Online
for Kindle Fire, Apple, Android, Nook, Kobo, PC, Mac, Sony Reader...
Most popular at the top
Cured I - Lent Late Effects of Cancer Treatment on Normal Tissues
Springer 2007; US$ 99.99The search for the most favorable therapeutic ratio ??? at which ablation of cancer is achieved while normal tissues are conserved ??? has been modern radiation oncology??'s equivalent of the quest for the Holy Grail. Our awareness of the late effects of radiation grew during the past century as new modalities were introduced. Heightened normal... more...
Advances in pharmacology and chemotherapy
Elsevier Science 1981; US$ 249.00ADV IN PHARMACOLOGY &CHEMOTHERAPY VOL 17 more...
Anticancer Therapeutics
Wiley 2008; US$ 199.95Written by the winner of the 2008 Mike Price Fellowship "This volume provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject." Anticancer Research, November - December 2008 This book provides a clear introduction to the area, with an overview of the various drug design and development... more...
Molecular Targeting in Oncology
Springer 2007; US$ 179.99In Molecular Targeting in Oncology, authors present an overview of the development of targeted therapies for the treatment of cancer with an emphasis on clinical application. The volume covers the complexity of the rapidly developing area of targeted therapies for the treatment of patients with cancer and is structured in a way so readers may begin... more...
Antiangiogenic Agents in Cancer Therapy
Springer 2008; US$ 159.99Antiangiogenesis remains a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials. Optimizing the therapeutic potential of antiangiogenic agents in combination with the other therapies in the armamentarium to fight cancer will... more...
Microtubule Targets in Cancer Therapy
Springer 2009; US$ 209.99The family of proteins called the tubulin and the microtubules they form when they aggregate are extremely important in the cell and, as we are increasingly learning, important in diseases that afflict so many. This title presents an exploration of the dynamic potential of microtubules anti-cancer targets. more...
History of Research on Tumor Angiogenesis
Springer 2008; US$ 129.99Emphasizes the crucial and paradigmatic role of angiogenesis as a biological process and the significance of antiangiogenic approach for the treatment of tumors. more...
Apoptosis in Carcinogenesis and Chemotherapy
Springer 2009; US$ 179.99Aims to provide information on apoptotic processes involved in major neoplastic diseases and their translations into anti-cancer strategies. This book describes how the apoptosis plays a role in the specific carcinogen-induced cellular and molecular changes during the development of the cancer. more...
Camptothecins in Cancer Therapy
Springer 2007; US$ 169.99This is a critical review of our current understanding of camptothecins, their shortcomings, and of the possibilities for improving their clinical performance. The authors discuss new camptothecin analog development, drug delivery issues for optimizing their anticancer activity, and their potential use in a variety of different cancers. Additional... more...
Bortezomib in the Treatment of Multiple Myeloma
Springer 2010; US$ 149.99Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome... more...
Top 10 Medicine bestsellers:
